Takanori Hidaka
Sendai, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 40 publications
Advancements in Whole-Genome Sequencing Protocols: A Decade of In-House Operations and Quality Controls at the Tohoku Medical Megabank.
Journal: JMA journal
Published: April 02, 2025
Systemic activation of NRF2 contributes to the therapeutic efficacy of clinically-approved KRAS-G12C anti-cancer drugs.
Journal: British journal of cancer
Published: January 07, 2025
Cohort Profile Update: The Tohoku Medical Megabank Project Birth and Three-Generation Cohort Study (TMM BirThree Cohort Study) 2023 update.
Journal: International journal of epidemiology
Published: March 26, 2024
Skin health survey on atopic dermatitis among Japanese children: The Tohoku Medical Megabank Project Birth and Three-Generation Cohort Study.
Journal: Allergology international : official journal of the Japanese Society of Allergology
Published: March 19, 2024
Plasminogen Activating Inhibitor-1 Might Predict the Efficacy of Anti-PD1 Antibody in Advanced Melanoma Patients.
Journal: Frontiers in oncology
Published: October 20, 2021
Chronological changes of skin eruptions toward cold abscess formation in hyper-immunoglobulin E syndrome.
Journal: The Journal of dermatology
Published: January 23, 2021
Possible Roles of Proinflammatory Signaling in Keratinocytes Through Aryl Hydrocarbon Receptor Ligands for the Development of Squamous Cell Carcinoma.
Journal: Frontiers in immunology
Published: February 12, 2020
Aryl Hydrocarbon Receptor Modulates Carcinogenesis and Maintenance of Skin Cancers.
Journal: Frontiers in medicine
Published: June 06, 2019
Successful Treatment of Unresectable Advanced Melanoma by Administration of Nivolumab With Ipilimumab Before Primary Tumor Resection.
Journal: Frontiers in medicine
Published: April 14, 2019
Biomarkers for Predicting Efficacies of Anti-PD1 Antibodies.
Journal: Frontiers in medicine
Published: March 20, 2019
BRAF kinase inhibitors for treatment of melanoma: developments from early-stage animal studies to Phase II clinical trials.
Journal: Expert opinion on investigational drugs
Published: December 18, 2018
Last Updated: 09/26/2026